Chaganti, R.S.K., and Nanjangud, G. Cytogenetics of lymphoma. In: Non-Hodgkin's lymphomas (Mauch, P.M., Armitage, J.O., Coiffier, B., and Dalla-Favera, R., Harris, N.L., eds.) Lippincott, Williams & Wilkins, Baltimore, pp809-824, 2003.
Pasqualucci, L., Migliazza, A., Chaganti, R.S.K., Ye, H. B., and Dalla-Favera, R. Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma. Blood 101: 2914-2923, 2003.
Teruya-Feldstein, J., Donnelly, G., Goy, A., Hegde, A., Nanjangud, G., Qin, J., Thaler, H., Gillies, F., Dyomin, V.G., Lloyd, K.O., Zelenetz, A.D., Houldsworth, J., and Chaganti, R.S.K. MUC-1 mucin expression correlates with advanced stage disease, adverse event-free and overall survival in diffuse large B-cell lymphoma. Appl. Immunohistochem. Mol. Morph. 11:28-32, 2003.
Houldsworth, J., Olshen, A.B., Cattoretti, G., Donnelly, G.B., Teruya-Feldstein, J., Qin, J., Palanisamy, N., Shen, Y., Dyomina, K., Petlakh, M., Pan, Q., Zelenetz, A.D., and Chaganti, R.S.K. Relationship between REL amplification, REL function, and clinical and biological feaures of diffuse large B-cell lymphoma. Blood. 103: 1862-1868, 2004.
Koul, S., McKiernan, J.M., Narayan, G., Houldsworth, J., Bacik, J., Dobrzynski, D.L., Assad, A.M., Manshukani, M., Reuter, V.E., Bosl, G.J., Chaganti, R.S.K., and Murty, V.V.V.S. Role of promoter hypermethylation in cisplatin treatment response of male germ cell tumors. Mol. Cancer 3:16.
Schmidt, H.H., Dyomin, V., Palanisamy, N., Itoyama, T., Nanjangud, G., Pric-Danoewinata, H., Haas, O.A., Chaganti, R.S.K. Deregulation of the carbohydrate (chondroitin 4) sulfotransferase II (CHSTII) gene in B-cellchronic lymphocytic leukemia with a t(12;14)(q23;q32). Oncogene. 23: 6991-6996, 2004.
Chadalavada, R.S., Houldsworth, J., Olshen, A.B., Bosl, G.J., Studer, L., Chaganti, R.S.K. Transcriptional program of bone morphogenetic protein-2-induced epithelial and smooth muscle differentiation of pluripotent embryonal carcinoma cells. Funct. Integr. Genomics. 5: 59-69, 2005.
Houldsworth, J., Bosl, G.J., and Chaganti, R.S.K. Genetics and biology of adult male germ cell tumors. In: Urological Cancers: Science and Treatment (Waxman, J., ed) Springer Verlag, London, pp221-229, 2005.
Korkola, J.E., Houldsworth, J., Dobrzynski, D., Olshen, A.B., Reuter, V.E., Bosl, G.J., and Chaganti, R.S. Gene expression-based classification of nonseminomatous male germ cell tumors. Oncogene 28: 5101-5107, 2005.
Banerjee, D., Chadalavada, R.S.V., Bourdon, V., Korkola, J.E., Motzer, R.J., and Chaganti, R.S.K. Transcriptional program associated with IFN-รก response of renal cell carcinoma. J. Interferon & Cytokine Res. 26: 156-170, 2006.
Chaganti, R.S.K. Testicular cancer. In: Encyclopedia of Life Sciences. John Wily & Sons, Ltd: Chichester, 2006.
Chen, W., Houldsworth, J., Olshen, A.B., Nanjangud, G., Chaganti, S., Venkataraman, E.S., Halaas, J., Teruya-Feldstein, J., Zelenetz, A.D., and Chaganti, R.S.K. Array comparative genomic hybridization reveals genomic copy number changes associated with outcome in diffuse large cell lymphomas. Blood 107:2477-2485, 2006.
Houldsworth, J., Bosl, G.J., and Chaganti, R.S.K. Biology and genetics of adult male germ cell tumors. In: Comprehensive Textbook of Genitourinary Oncology, Third Edition (Vogelzanf, N.J., Scardino, P.T., Shipley, W.U., Debruyne, M.J., Linehan, M., eds), Baltimore, Lippincott Williams & Wilkins, New York, pp563-571, 2005.
Korkola, J.E., Houldsworth, J., Chadalavada, R., Olshen A.B., Dobrzynski, D., Reuter, V.E., Bosl, G.J., and Chaganti, R.S.K. Down-regulation of stem cell genes, including those in a 200kb gene cluster at 12p13.31 is associated with in vivo differentiation of human male germ cell tumors. Cancer Res. 66:820-827, 2006.
Chadalavada, R.S.V., Korkola, J.E., Houldsworth, J., Olshen, A.B., Bosl, G.J., Studer, L., Chaganti, R.S.K. Constitutive gene expression predisposes morphogen-mediated cell fate responses of NT2/D1 and 27X-1 embryonal carcinoma cells. Stem Cells 25: 771-8, 2007.
Chaganti, R.S.K. Genetics of cancer. In: Cecil Medicine. 23rd Edition. Saunders, Elsevier, Philadelphia, pp1340-1344, 2007.
Narayan G., Bourdon, V., Chaganti, S., Arias-Pudilo, H., Nandulu, S.V., Rao, P.H., Gissmann, L., Durst, M., Schneider, A., Pothuri, B., Mansukhani, M., Basso, K., Chaganti, R.S.K., Murty, V.V. Gene dosage alterations revealed by cDNA microarrys analysis in cervical cancer: Identification of candidate amplified and overexpressed genes. Genes, Chromosomes & Cancer 46: 373-384, 2007.
Nanjangud, G., Rao, P.H., Teruya-Feldstein, J., Donnelly, G., Qin, J., Mehra, S., Jhanwar, S.C., Zelenetz, A.D., Chaganti, R.S.K. Molecular cytogenetic analysis of follicular lymphoma (FL) provides detailed characterization of chromosomal instability associated with the t(14;18)(q32;q21) positive and negative sub sets and histologic progression. Cytogenet. Genome Res. 118: 337-344, 2007.
Korkola, J.E., Heck, S., Olshen, A.B., Reuter, V.E., Bosl, G.J., Houldsworth, J., Chaganti, R.S.K. In vivo differentiation and genomic evolution in adult male germ cell tumors. Genes, Chromosomes and Cancer 47: 43-55, 2008.
Bosl, G.J., Bajorin, D.F., Sheinfeld, J., Motzer, R.J., Chaganti, R.S.K. Testis Cancer. In: DeVita, Hellman and Rosenberg's Cancer: Principles and Practice of Oncology. Eighth Edition (DeVita, V.T., Lawrence, T.S., Rosenberg, S.A., eds). Lippincott Williams & Wilkins, Philadelphia pp 1463-1485.
Houldsworth, J., Petlakh, M., Olshen, A.B., and Chaganti, R.S.K. Pathway activation in large B-Cell non-Hodgkin's lymphoma cell lines by doxorubicin reveals prognostic markers of In Vivo response. Leukemia & Lymphoma (in press)
Nanjangud, G., Palanisamy, N., and Chaganti, R.S.K. Cytogenetic analysis and related techniques in hematopathology. (Jaffe, E.S., Harris, N.L., Vardiman, J.W., eds), New York (In press).
|
